Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2013
03/20/2013CN102133235B Toad peptide antibiotic medicine for treating phthisis
03/20/2013CN102101888B Novel polypeptide for resisting tumors caused by EB (Epstein-Barr) viruses, and application and preparation method thereof
03/20/2013CN102093250B Refining method of alanyl-glutamine compound
03/20/2013CN102079765B 9-O-glucoside-berberine salt, and preparation method and application thereof
03/20/2013CN102060793B Dual aryl tertiary amine azole compounds with biological activity as well as preparation method and medical application thereof
03/20/2013CN102008531B Fufukang gel and preparation method thereof
03/20/2013CN101977616B Method for producing a mixture of bacteriophages and the use thereof in the therapy of antibiotic-resistant staphylococci
03/20/2013CN101951922B Preparation for treating intestinal infection comprising oligosaccharides and insoluble cellular material
03/20/2013CN101948784B Bdellovibrio bacteriovorus preparation and fermentation method and application thereof
03/20/2013CN101940606B Medicinal composition for treating condyloma acuminatum and verruca plana and preparation process thereof
03/20/2013CN101940573B Composition of cefamandole sodium and sulbactam sodium and mixture ratio thereof
03/20/2013CN101926992B Recombined attenuated live vaccine for preventing and treating I-type infection of herpes simplex virus and preparation method thereof
03/20/2013CN101906166B Streptococcus recombination subunit vaccine and preparation method
03/20/2013CN101863963B Helicobacter pylori antigen epitope polypeptide and application thereof
03/20/2013CN101862028B Wintergreen extraction method, preparation method of cigarette comprising wintergreen extract
03/20/2013CN101843653B Processing method of Chinese stellera root condensed decoction
03/20/2013CN101785789B Method for preparing animal gall powder
03/20/2013CN101768565B Bacillus anthracis capable of displaying PAD4 protein on surface of spore and application thereof
03/20/2013CN101624360B Substituted organic sulfur compound and application thereof
03/20/2013CN101623306B Bracken pill and preparation method thereof
03/20/2013CN101496820B Active extract of facultative anaerobic sea Pseudomonas stuszeri as well as production method and use thereof
03/20/2013CN101480429B Chinese medicine preparation for treating external infection
03/20/2013CN101429107B Lignanoid compounds, producing method, identification method and uses thereof
03/20/2013CN101391986B Fluorine triazole ethers derivates and salt with antimicrobial activity, preparation method and uses thereof
03/19/2013US8399655 Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1′-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof
03/19/2013US8399650 Mycobacterial antigens expressed during latency
03/19/2013US8399617 Non-functional P2X7 receptor
03/19/2013US8398996 Staphylococcus aureus proteins and nucleic acids
03/19/2013US8398990 Glucan-based vaccines
03/19/2013US8398980 Subtypes of humanized antibody against interleuken-6 receptor
03/19/2013CA2719531C New ruthenium complexes as catalysts for metathesis reactions
03/19/2013CA2712783C Beta-lactamase inhibitors
03/19/2013CA2706872C Intermediates for the preparation of lipoxin a4 analogs
03/19/2013CA2586873C Topical compositions comprising myrica gale oil
03/19/2013CA2549228C Hiv protease inhibiting compounds
03/19/2013CA2471702C Human monoclonal antibodies against cd30
03/19/2013CA2453260C Vaccine formulation potentiated by the combination of a dna and an antigen
03/19/2013CA2319465C Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
03/19/2013CA2311647C Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
03/14/2013WO2013035906A1 Method for preventing and treating salmonella typhimurium infection
03/14/2013WO2013035579A1 Liver-accumulative nanoparticle having drug encapsulated therein
03/14/2013WO2013035331A1 Oral composition
03/14/2013WO2013034758A1 Substituted triazolopyrazines and uses thereof
03/14/2013WO2013034726A1 Nanoparticle-peptide compositions
03/14/2013WO2013034670A1 Preparation of micafungin intermediates
03/14/2013WO2013034087A1 Doripenem hydrate crystal and preparation method therefor
03/14/2013WO2013034069A1 Recombinant influenza virus highly expressing ha protein and preparation method and use thereof
03/14/2013WO2013034048A1 Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
03/14/2013WO2013034047A1 Heterocyclic-substitued benzofuran derivatives and methods of use thereof for the treatment of viral diseases
03/14/2013WO2013033971A1 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
03/14/2013WO2013033901A1 Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
03/14/2013WO2013033900A1 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
03/14/2013WO2013033899A1 Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
03/14/2013WO2013033862A1 4-substituted-(3-substituted-1h-pyrazole-5-amino)-pyrimidine derivatives having activity of inhibiting protein kinase and use thereof
03/14/2013WO2013033797A1 Pharmaceutical composition for treatment of burns and injuries of the skin and its preparation process
03/14/2013WO2013011179A3 Recombinant vectors based on the modified vaccinia ankara (mva) virus, with deletion in the c6l gene, as vaccines against hiv/aids and other diseases
03/14/2013WO2012177986A3 Conjugate-based antifungal and antibacterial prodrugs
03/14/2013WO2012173392A3 Curcuminoid-based compound/stevioside-containing complex for the prevention and treatment of an influenza virus infection
03/14/2013WO2012170842A3 Peptide for protection of allergic respiratory disorders
03/14/2013WO2012162089A3 Sgef controls macular, corpus callosum and hippocampal function and development, liver homeostasis, functions of the immune system, fever response atherosclerosis and tumorogenic cell growth
03/14/2013WO2012141674A3 Compositions and methods relating to argininosuccinate synthetase
03/14/2013WO2012135177A3 Methods and compositions for cytomegalovirus il-10 protein
03/14/2013WO2012112862A3 Treating mycobacterial infection with cu+/++ boosting therapeutics
03/14/2013US20130065967 Use of methylsulfonylmethane (msm) to inhibit microbial activity
03/14/2013US20130065962 Compounds For Use In The Treatment Of Diseases
03/14/2013US20130065944 Reverse micelle system comprising nucleic acids and use thereof
03/14/2013US20130065943 Compositions and methods for inhibiting expression of cd45 gene
03/14/2013US20130065941 Compositions and their uses for gene therapy of bone conditions
03/14/2013US20130065935 Novel Inhibitors of the Amino Acid Transporters ASCT1 and ASCT2
03/14/2013US20130065917 Salt of naphthyridine carboxylic acid derivative
03/14/2013US20130065905 Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine
03/14/2013US20130065897 Compounds, preparation and uses thereof
03/14/2013US20130065889 2,5-disubstituted arylsulfonamide ccr3 antagonists
03/14/2013US20130065884 Anti-Infective Compounds
03/14/2013US20130065883 Triazolo [4, 5- B] Pyridin Derivatives
03/14/2013US20130065881 Tricyclic Compounds for Use as Kinase Inhibitors
03/14/2013US20130065878 Cell-free preparation of carbapenems
03/14/2013US20130065875 Small molecule inhibitors of hepatitis c virus
03/14/2013US20130065874 Methods for treating intrapulmonary infections
03/14/2013US20130065873 Metal complexes
03/14/2013US20130065866 Dentinal drug delivery composition and screening method
03/14/2013US20130065865 Barrier film-forming germicidal composition for controlling mastitis
03/14/2013US20130065862 Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
03/14/2013US20130065861 Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc.
03/14/2013US20130065858 Compounds useful as raf kinase inhibitors
03/14/2013US20130065857 Novel dxr inhibitors for antimicrobial therapy
03/14/2013US20130065856 Tenofovir alafenamide hemifumarate
03/14/2013US20130065851 Anti-viral formulations
03/14/2013US20130065850 Treatment of viral infections by modulation of host cell metabolic pathways
03/14/2013US20130065848 Levoisovalerylspiramycin i, ii or iii, preparations, prepartation methods and uses thereof
03/14/2013US20130065845 Triazole Compounds and Methods of Making and Using the Same
03/14/2013US20130065844 Compositions of Stable Tiacumicins
03/14/2013US20130065827 Crystalline Peptide Epoxyketone Immunoproteasome Inhibitor
03/14/2013US20130065819 Target of egr1 (toe1) polypeptides for inhibition of hiv
03/14/2013US20130065818 Arylamide Compounds And Compositions And Uses Thereof
03/14/2013US20130065816 Analogs of pituitary adenylate cyclase-activating polypeptide (pacap) and methods for their use
03/14/2013US20130064912 Formulation for alleviation of kidney stone and gallstone symptoms
03/14/2013US20130064889 Tablet-in-tablet Palperidone Formulations and Methods for Production and Use Thereof
03/14/2013US20130064883 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
03/14/2013US20130064879 Compositions and Methods for Inhibiting Viral Replication
1 ... 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 ... 1798